"SMART" drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers. - Wikidata - awgldk - TriplyDB

"SMART" drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers.

"SMART" drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers.

http://www.wikidata.org/entity/Q42544966

about

siRNA Delivery by Stimuli-Sensitive Nanocarriers Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systems CPP-Assisted Intracellular Drug Delivery, What Is Next?pH-sensitive nanomicelles for controlled and efficient drug delivery to human colorectal carcinoma LoVo cells Recent advances on smart TiO2 nanotube platforms for sustainable drug delivery applications.Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.The use of therapeutic peptides to target and to kill cancer cells.Molecular plasmonics for biology and nanomedicine.Quantitative analysis of the fate of gold nanocages in vitro and in vivo after uptake by U87-MG tumor cells.Intracellular trafficking of silicon particles and logic-embedded vectors Acid-triggered release via dePEGylation of fusogenic liposomes mediated by heterobifunctional phenyl-substituted vinyl ethers with tunable pH-sensitivity Modification of hydrophilic and hydrophobic surfaces using an ionic-complementary peptide Highly stable noble metal nanoparticles dispersible in biocompatible solvents: synthesis of cationic phosphonium gold nanoparticles in water and DMSO.Single-step surface functionalization of polymeric nanoparticles for targeted drug delivery.Polymer--cisplatin conjugate nanoparticles for acid-responsive drug delivery Endocytosis of nanomedicines.Challenges associated with Penetration of Nanoparticles across Cell and Tissue Barriers: A Review of Current Status and Future Prospects.A tumor-acidity-activated charge-conversional nanogel as an intelligent vehicle for promoted tumoral-cell uptake and drug delivery.Zwitterionic chitosan derivatives for pH-sensitive stealth coating.Development of a reduction-sensitive diselenide-conjugated oligoethylenimine nanoparticulate system as a gene carrier.Folic acid-tethered Pep-1 peptide-conjugated liposomal nanocarrier for enhanced intracellular drug delivery to cancer cells: conformational characterization and in vitro cellular uptake evaluation.Acetal-derivatized dextran: an acid-responsive biodegradable material for therapeutic applications Delivery of siRNA into breast cancer cells via phage fusion protein-targeted liposomes.The effect of sedimentation and diffusion on cellular uptake of gold nanoparticles.Release of liposomal contents by cell-secreted matrix metalloproteinase-9 Enhanced affinity bifunctional bisphosphonates for targeted delivery of therapeutic agents to bone.Mannosylated liposomes for targeted gene delivery.Drug release from hydrazone-containing peptide amphiphiles.Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery TAT peptide-based micelle system for potential active targeting of anti-cancer agents to acidic solid tumors.Comparison of two kinds of nanomedicine for targeted gene therapy: premodified or postmodified gene delivery systems.Supramolecular assembly of crosslinkable monomers for degradable and fluorescent polymer nanoparticles A detachable coating of cholesterol-anchored PEG improves tumor targeting of cell-penetrating peptide-modified liposomes Liver cell specific targeting by the preS1 domain of hepatitis B virus surface antigen displayed on protein nanocages Effects of pH-sensitive chain length on release of doxorubicin from mPEG-b-PH-b-PLLA nanoparticles.Beyond the imaging: limitations of cellular uptake study in the evaluation of nanoparticles.Harnessing the power of cell-penetrating peptides: activatable carriers for targeting systemic delivery of cancer therapeutics and imaging agents.pH-sensitive poly(histidine)-PEG/DSPE-PEG co-polymer micelles for cytosolic drug delivery Sheddable coatings for long-circulating nanoparticles.Curb challenges of the "Trojan Horse" approach: smart strategies in achieving effective yet safe cell-penetrating peptide-based drug delivery.

P2860

Q26781212-7F2411DB-0344-45B2-94C6-1EB3994FAB46 Q26996159-BB2C6AE4-F4EC-48A7-9DB0-7FD57E5031C1 Q28079386-2FB9E461-6611-422D-9F83-B38D4BC6A978 Q28540012-E2EC8D54-1517-4890-B9FE-1CEA44AC2FE8 Q28818556-B842A581-94FB-4097-BBFB-5A6D36E0AA05 Q30366990-0A931D47-E22A-455F-90DA-E64FBC2F5DBF Q30418414-F86FF1A2-ACCD-44D5-ABC1-C908BFB9E592 Q30439956-CD29E7AA-850C-4073-9E36-22831DD3E861 Q30444211-C4638CE1-D3AE-4544-BDB1-C14711A372E7 Q30496512-392B2932-ACCA-45AD-ACF2-8A2B45F61985 Q30525820-DA6E563B-B90A-4801-890C-EA06441A747F Q30839602-9C9D489C-9FD6-4FB0-BC16-60C9D90730A2 Q31038938-BEA1E886-C5A0-4AC0-80BE-8C9DB3C703E3 Q33385557-D478C95A-E022-4DAB-95F5-81EBEACFE5F1 Q33695863-8C7E33E4-B60A-4C48-BB19-BD08B11D7637 Q33987301-658047C8-43A5-4518-9920-6779FD40C77D Q34030709-4CA416AD-C911-4DB1-BA30-568EAB7E2173 Q34110105-6C1B12B8-763A-4D5E-950B-B0B2E7F13C14 Q34139159-69D03D52-F6DB-4FB4-B7D7-DF83516745DD Q34384071-2EEE1FC2-09B2-493D-AE48-876EF2BBE9F8 Q34628862-AB84B49C-F05F-4770-8EC8-CD4604BA10E1 Q34796662-5E94AED6-E78F-4FB7-AB2F-1D12EA867F78 Q35024345-187E4960-06DE-4072-8EA2-4C2FB7D5EC0D Q35583445-B54C6E35-4933-4C68-A612-EB04FD093BBD Q35636788-1B1D686F-26E1-401A-A56D-4358899A9A74 Q35637157-8AED9AAB-7942-44F7-B3B3-12E586AFCB7E Q35787498-36D0D757-6E46-4E63-B548-4E4C7A77B770 Q35796515-9696752C-B06A-489D-A052-60BC0E2F6530 Q35809872-01C4EBD5-3FFF-4A21-BB91-6282340ABB7D Q35968339-F06E96E8-CBE9-4EA7-9BF7-8C6865B93486 Q35972662-6CB3B83D-9904-438F-8ED7-9FF5B99D7922 Q36092141-10368AD2-81B7-4114-B76D-C498B8F03D20 Q36110850-3E185C1D-AC44-4E46-AB13-3E55C4A29501 Q36168987-4AD0EC0A-A582-446D-B9DC-F3C73910AD54 Q36176104-BA412366-D529-4D87-A559-3164DD718D27 Q36247616-6FA4EE84-7BB0-43F2-BE95-2C97B06FA92E Q36612939-4C1A7756-4785-4D39-B458-3FBA0020972D Q36653608-22C5C7FA-F4F1-44F8-923D-AEF7A908D6F7 Q36841604-72C01CBE-789A-4F6F-B5EA-79B2E168EC50 Q36854231-09565F2D-8ED3-436E-B41C-DD39B9FEFC07

P2860

"SMART" drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers.

http://www.wikidata.org/entity/Q42544966

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

"SMART" drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers.

@en

"SMART" drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers.

@nl

type

label

"SMART" drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers.

@en

"SMART" drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers.

@nl

prefLabel

"SMART" drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers.

@en

"SMART" drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers.

@nl

P1433

Q42544966-5FAB02E3-3EF4-4F61-99CC-6D34647C2D68

P1476

Q42544966-0D29E8A8-2731-48F0-A37A-25685A697F99

P2093

Q42544966-72D47E5C-7EEA-451C-B189-3B3FECCEF2E0

Q42544966-CB0C45A6-7A43-4404-AAB8-D30136015ACC

Q42544966-D7F690C5-F28A-4654-9924-D856DF9A3C38

Q42544966-EF57A615-AADE-4F8C-9AF5-BB851AF1E81F

Q42544966-EF95EBFF-14B0-4F78-B61C-D4E702008F17

Q42544966-FB027FF2-BDA0-4A9A-9C1D-0330BE4534B2

Q42544966-FFEAB765-9907-4C01-92D1-5052099F7297

P2860

Q42544966-0091A1C9-4ED8-45F6-A3E5-4BE06CA9F692

Q42544966-29F49FEE-3261-418D-A33D-A246318B84E1

Q42544966-33FF787F-45D4-4536-B8AC-23B9F454C709

Q42544966-42995A06-A21C-4056-B7A5-E740C6B47C4D

Q42544966-524869A4-7207-4CB6-9BAA-85BC316E9B3A

Q42544966-54FBB133-D3E9-4E2B-A4F5-F4050A26438A

Q42544966-5B2985E0-1666-4F77-A352-7B0AD7F191B4

Q42544966-60BBA889-80A7-463E-A9E4-CA4097862389

Q42544966-64BFE9FE-0CFE-43BB-B673-310A0C72A5F4

Q42544966-69304BB0-926D-44B7-BA14-0D55289B5AD4

P304

Q42544966-6F8D9361-69D4-40BA-BC9B-70E5B88D701B

P31

Q42544966-78C05C87-8686-49F4-A2C1-E2C70BF7824C

P356

Q42544966-75511C55-CB4C-4E60-9EF6-F8B78504E3A7

P433

Q42544966-CF1ADBCC-7F06-4E45-B47E-E624C584857F

P478

Q42544966-C8D7E919-02ED-4FE8-939C-D1CCBE256F42

P577

Q42544966-7424FD19-02FA-4633-98B5-61B96A43C37B

P5875

Q42544966-D373679F-08CA-44DF-A041-621FBFEEFC13

P698

Q42544966-F7E1620A-0A3E-4DE5-8221-3C581760D9B8

P921

Q42544966-30310461-598E-436F-B574-FF42FCDB5904

Q42544966-F6182DE4-101F-4690-BBE1-475DD21F2CBD

P932

Q42544966-E9B8AC24-DCFC-473A-BD25-B64E5FF6D485

P356

P1433

Bioconjugate Chemistry

P1476

"SMART" drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers.

@en

P2093

A Kale

http://www.w3.org/2001/XMLSchema#string

E Tolcheva

http://www.w3.org/2001/XMLSchema#string

J P Hurley

http://www.w3.org/2001/XMLSchema#string

R M Sawant

http://www.w3.org/2001/XMLSchema#string

S Salmaso

http://www.w3.org/2001/XMLSchema#string

T S Levchenko

http://www.w3.org/2001/XMLSchema#string

V P Torchilin

http://www.w3.org/2001/XMLSchema#string

P2860

In vivo protein transduction: delivery of a biologically active protein into the mouse

Recent advances with liposomes as pharmaceutical carriers

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

Soluble biodegradable polymer-based cytokine gene delivery for cancer treatment.

Targeted polymeric micelles for delivery of poorly soluble drugs.

Endosomes, lysosomes: their implication in gene transfer.

The mechanism of liposome accumulation in infarction.

Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes.

Tat-mediated delivery of heterologous proteins into cells.

Immunomicelles: targeted pharmaceutical carriers for poorly soluble drugs.

P304

943-949

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/BC060080H

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2006-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6938226

http://www.w3.org/2001/XMLSchema#string

P698

16848401

http://www.w3.org/2001/XMLSchema#string

P921

P932

2538444

http://www.w3.org/2001/XMLSchema#string